afatinib EGFR Codon 719 Missense, +4 more biomarkers Non-Small Cell Lung Carcinoma Metastatic First line afatinib targeted therapy
afatinib EGFR A763_Y764insFQEA, +4 more biomarkers Non-Small Cell Lung Carcinoma Advanced, +1 more state First line afatinib targeted therapy
afatinib + cetuximab EGFR A763_Y764insFQEA, +6 more biomarkers Non-Small Cell Lung Carcinoma Advanced, +1 more state Subsequent line afatinib, +1 more drug targeted therapy
erlotinib EGFR A763_Y764insFQEA, +5 more biomarkers Non-Small Cell Lung Carcinoma Advanced, +1 more state First line erlotinib targeted therapy
gefitinib EGFR A763_Y764insFQEA, +5 more biomarkers Non-Small Cell Lung Carcinoma Advanced, +1 more state First line gefitinib targeted therapy
osimertinib EGFR A763_Y764insFQEA, +5 more biomarkers Non-Small Cell Lung Carcinoma Advanced, +1 more state First line osimertinib targeted therapy
dacomitinib EGFR A763_Y764insFQEA, +4 more biomarkers Non-Small Cell Lung Carcinoma Advanced, +1 more state First line dacomitinib targeted therapy
Cancer Search
